2 results match your criteria: "Irma Lerma Rangel (ILR) College of Pharmacy Texas A&M Health Science Center[Affiliation]"

Although constitutive activation of Janus kinase 3 (Jak3) leads to different cancers, the mechanism of trans-molecular regulation of Jak3 activation is not known. Previously we reported that Jak3 interactions with adapter protein p52ShcA (Shc) facilitate mucosal homeostasis. In this study, we characterize the structural determinants that regulate the interactions between Jak3 and Shc and demonstrate the trans-molecular mechanism of regulation of Jak3 activation by Shc.

View Article and Find Full Text PDF

Identification of molecular switch regulating interactions of Janus kinase 3 with cytoskeletal proteins.

J Biol Chem

November 2012

Department of Pharmaceutical Sciences, Irma Lerma Rangel (ILR) College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas 78363, USA.

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Although mutations that abrogate Jak3 functions cause different immunological disorders, its constitutive activation leads to various types of cancer. Previously, we demonstrated that Jak3 interacted with actin-binding protein villin, thereby facilitating cytoskeletal remodeling and wound repair.

View Article and Find Full Text PDF